Haiwei Yang

5.2k total citations · 3 hit papers
92 papers, 3.8k citations indexed

About

Haiwei Yang is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Haiwei Yang has authored 92 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 23 papers in Immunology and 23 papers in Cancer Research. Recurrent topics in Haiwei Yang's work include RNA modifications and cancer (19 papers), Cancer-related molecular mechanisms research (15 papers) and Circular RNAs in diseases (14 papers). Haiwei Yang is often cited by papers focused on RNA modifications and cancer (19 papers), Cancer-related molecular mechanisms research (15 papers) and Circular RNAs in diseases (14 papers). Haiwei Yang collaborates with scholars based in China, Canada and United States. Haiwei Yang's co-authors include Xiao Yang, Jie Han, Ji‐Fu Wei, Hao Yu, Qiang Lü, Wenbo Yuan, Jun Tao, Zijian Zhou, Jingzi Wang and Hongcheng Lu and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Urology.

In The Last Decade

Haiwei Yang

91 papers receiving 3.8k citations

Hit Papers

METTL3 promote tumor proliferation of bladder cancer by a... 2018 2026 2020 2023 2019 2018 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haiwei Yang China 28 2.8k 1.8k 383 362 330 92 3.8k
Ingeborg van der Made Netherlands 27 1.9k 0.7× 1.1k 0.6× 572 1.5× 151 0.4× 340 1.0× 46 3.0k
Wai Ho Tang China 18 2.1k 0.8× 1.1k 0.6× 326 0.9× 137 0.4× 247 0.7× 28 3.0k
Regalla Kumarswamy Germany 20 2.6k 0.9× 2.2k 1.2× 234 0.6× 225 0.6× 239 0.7× 23 3.5k
Bing Chen China 27 2.0k 0.7× 1.2k 0.7× 375 1.0× 470 1.3× 183 0.6× 151 3.1k
Canwen Jiang United States 28 1.7k 0.6× 564 0.3× 242 0.6× 166 0.5× 307 0.9× 43 3.5k
Jipeng Li China 34 1.9k 0.7× 1.5k 0.8× 221 0.6× 453 1.3× 251 0.8× 105 2.9k
Mark W.M. Schellings Netherlands 18 1.1k 0.4× 777 0.4× 111 0.3× 175 0.5× 363 1.1× 24 2.3k
Jiqiu Chen United States 22 1.3k 0.5× 388 0.2× 387 1.0× 174 0.5× 534 1.6× 42 2.6k
Dong Li China 30 1.7k 0.6× 1.1k 0.6× 227 0.6× 252 0.7× 275 0.8× 121 2.8k

Countries citing papers authored by Haiwei Yang

Since Specialization
Citations

This map shows the geographic impact of Haiwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiwei Yang more than expected).

Fields of papers citing papers by Haiwei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiwei Yang. The network helps show where Haiwei Yang may publish in the future.

Co-authorship network of co-authors of Haiwei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Haiwei Yang. A scholar is included among the top collaborators of Haiwei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiwei Yang. Haiwei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Ming, Hao Yu, Rui Zhou, et al.. (2024). CircFAM64A(3) promoted bladder cancer proliferation and inhibited CD8 + T cell via sponging to miR-149-5p and activated IL-6/JAK/STAT pathway. International Immunopharmacology. 145. 113762–113762. 2 indexed citations
2.
Yu, Hao, Zijian Zhou, Jiancheng Lv, et al.. (2024). METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway. International Journal of Biological Sciences. 20(4). 1471–1491. 22 indexed citations
4.
Song, Qiang, Hao Yu, Yidong Cheng, et al.. (2022). Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment. Journal of Translational Medicine. 20(1). 308–308. 43 indexed citations
5.
Yang, Xiao, Jiancheng Lv, Zijian Zhou, et al.. (2022). Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity. Frontiers in Oncology. 11. 802188–802188. 22 indexed citations
6.
Song, Qiang, Hao Yu, Jie Han, et al.. (2022). Exosomes in urological diseases - Biological functions and clinical applications. Cancer Letters. 544. 215809–215809. 18 indexed citations
7.
Zhang, Xiaolei, Feng Wang, Zijie Wang, et al.. (2020). ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner. Annals of Translational Medicine. 8(10). 646–646. 60 indexed citations
8.
Han, Jie, Xiao Yang, Hao Yu, et al.. (2019). METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Molecular Cancer. 18(1). 110–110. 546 indexed citations breakdown →
9.
Tang, Jingyuan, Feng Wang, Gong Cheng, et al.. (2018). Wilms’ tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability. Journal of Experimental & Clinical Cancer Research. 37(1). 40–40. 148 indexed citations
10.
Yang, Chengdi, Wenbo Yuan, Xiao Yang, et al.. (2018). Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression. Molecular Cancer. 17(1). 19–19. 398 indexed citations breakdown →
11.
Li, Peng, Xiao Yang, Yidong Cheng, et al.. (2017). MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1. Cellular Physiology and Biochemistry. 41(3). 921–932. 81 indexed citations
12.
Yang, Haiwei, Hao Chen, Min Jin, et al.. (2016). Molecular cloning, expression, IgE binding activities and in silico epitope prediction of Per a 9 allergens of the American cockroach. International Journal of Molecular Medicine. 38(6). 1795–1805. 12 indexed citations
13.
Ding, Zhi‐Ming, Haiwei Yang, Tiansong Xia, Bo Wang, & Qiang Ding. (2015). Integrative genomic analyses of the RNA-binding protein, RNPC1, and its potential role in cancer prediction. International Journal of Molecular Medicine. 36(2). 473–484. 13 indexed citations
14.
Chang, Xin, Haiwei Yang, Yanan Xu, et al.. (2015). Upregulated expression of CCR3 in osteoarthritis and CCR3 mediated activation of fibroblast-like synoviocytes. Cytokine. 77. 211–219. 28 indexed citations
15.
Wang, Ming‐Hai, et al.. (2014). Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction. International Journal of Molecular Medicine. 33(4). 1019–1026. 31 indexed citations
16.
Xu, Yuhong, Shutong Shen, Lizhou Sun, et al.. (2014). Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis. PLoS ONE. 9(1). e87863–e87863. 127 indexed citations
17.
Wei, Ji‐Fu, Liming Yang, Haiwei Yang, et al.. (2011). Analysis of Properties and Proinflammatory Functions of Cockroach Allergens Per a 1.01s. Scandinavian Journal of Immunology. 74(3). 288–295. 12 indexed citations
18.
Zhang, Huiyun, et al.. (2010). Induction of IL-13 production and upregulation of gene expression of protease activated receptors in P815 cells by IL-6. Cytokine. 50(2). 138–145. 20 indexed citations
19.
Zhang, Huiyun, Haiwei Yang, Wenjing Ma, & Shaoheng He. (2010). Induction of IL-13 production and upregulated expression of protease activated receptor-1 by RANTES in a mast cell line. Cytokine. 53(2). 231–238. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026